The mortality rate from liver malignant neoplasms among females in Germany shows a forecasted increase from 2024 to 2028, progressing from 2.88 to 2.97 thousand female deaths. Observing a stable uptrend, the annual growth rate is modest, highlighting an increase in mortality. Given the small percentage change and considering the CAGR, the data suggests a consistent yet minimal positive growth over the specified period.
Future trends to watch for include advancements in medical treatments, public health interventions leading to awareness and lifestyle changes impacting liver health, and possible influences from environmental or genetic research discoveries. Monitoring these factors may provide opportunities to curb the increasing mortality rate.
